Petosemtamab

Hi Jim

Can you give the name of the trial ? 

Edit. I found it.

I'm not sure of the protocol here but I wish you the best in getting help 

Thanks Dani.

I’ll pursue a judicial review on my own if that’s what it takes but the case is much stronger if it can be shown that the withholding of such a drug affects a significant number of people.

I've looked up the timeline. The trial started in July this year and doesn't report till February 2028 so nobody can gauge efficacy till then. 

However I have found a very useful publication in the journal of the Royal Society of Medicine concerning the ethics of trials. I've sent you a friend request so that I can give you the link

Not sure what trial you’re looking at. Mine started in April. Phase 2 efficacy was reported as 66% in the UK. Phase 3 trials in the US reported results in the seventies.

NCT06496178

I am making assumptions. You are best placed so sorry

Nevertheless you should look at the publication on the ethics of trials. 

Thanks for sending me the link - I may have read it already but, once I’ve figured out how to access it…. I’m new to this forum. ;-)

OK Google 

Giving and taking; ethical treatment assignment in controlled trials and click on the sage journals publication

I have read it before but thanks anyway.

It relates to trials involving placebos, which was not the case for me.

(Docetaxel was the standard of care arm - and I was informed that I would be placed on this arm beforehand)

JimDelaney961136 said:

I have read it before but thanks anyway.

Yes I should have realised. Awful situation you are in. 
i can’t recall anybody else on this drug but maybe somebody will pick up

Very very frustrating when, in all likelihood, I would be in remission by now, had I been given Petosemtamab.

It’s exciting knowing that there are some excellent treatments in the pipeline, nonetheless.